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Effects of protein or amino-acid supplementation on the
physical growth of young children in low-income countries
Joanne E. Arsenault and Kenneth H. Brown
Child growth stunting is common in low-income countries, possibly due to insufficient
protein intakes. Most previous studies have concluded that children’s protein intakes
are adequate in relation to estimated requirements, but these studies did not consider
issues of protein digestibility and effects of infection on dietary protein utilization.
Using an alternative approach to assess the possible role of protein inadequacy in
children’s growth restriction, the results of 18 intervention trials in which supplemen-
tary protein or amino acids were provided to children ages 6–35 months and growth
outcomes were reviewed. Eight studies conducted in hospitalized children recovering
from acute malnutrition found that the recommended protein intake levels for healthy
children supported normal growth rates, but higher intakes were needed for acceler-
ated rates of “catch-up” growth. Ten community-based studies did not demonstrate a
consistent benefit of supplemental protein on children’s growth. However, weaknesses
in the study designs limit the conclusions that can be drawn from these studies, and
additional appropriately designed trials are needed to answer this question defini-
tively. Recommendations for optimizing future study designs are provided herein.
INTRODUCTION
Approximately one-third of children aged<5 years
worldwide have stunted linear growth, defined as a
height-for-age Z score (HAZ)<2 standard deviations
(SDs) with respect to international growth standards.
Stunting is associated with an increased risk of child mor-
tality, infectious disease morbidity, impaired neurocogni-
tive development, and metabolic diseases in later life; it is,
therefore, of critical concern for public health.1 Stunting is
attributable to multiple factors, including small-for-
gestational-age and preterm births, inadequate dietary
quantity and quality, morbidity from infections, and poor
child-care practices.1,2 Among the multiple nutritional fac-
tors that affect growth, adequate protein is needed for tis-
sue synthesis in addition to the amount required for
maintenance of normal body functions.
Research on dietary protein adequacy in low-
income countries indicates the vast majority of young
children consume more protein than specified in pub-
lished estimates of protein requirements,3–5 resulting in
the common understanding that growth restriction is
not due to protein deficiency. Therefore, other nutri-
tional and nonnutritional causes of growth restriction
have been investigated. However, recent controversies
regarding the methods for assessing dietary protein ad-
equacy create uncertainty about the possible role of
dietary protein inadequacy in growth restriction. For
example, a report published by the Food and
Agriculture Organization of the United Nations (FAO)
in 2013 suggested that the true availability of amino acids
from the diet may be less than currently assumed when
estimates of protein digestibility are based on fecal nitro-
gen excretion (so-called “fecal digestibility”) rather than
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individual amino-acid digestibility and uptake in the
ileum (ie, “ileal digestibility”).6 However, little informa-
tion is currently available on ileal digestibility for individ-
ual amino acids, so it is not possible to adjust protein
intake accordingly. In addition, previous studies of pro-
tein intake adequacy did not use currently recommended
dietary assessment methods, such as (1) including mul-
tiple days of individual observations to establish the
population distribution of usual intakes, (2) applying the
estimated average requirement cut-point method to as-
sess prevalence of low intakes below requirements, and
(3) adjusting for protein quality. Furthermore, these
studies were unable to adjust for the effects of infections
on protein utilization. Because of these uncertainties in
the interpretation of studies of dietary protein adequacy,
an alternative approach to assessing the possible role of
protein in growth restriction is to examine the impact of
supplemental protein on children’s growth. This article
briefly reviews current estimates of young children’s pro-
tein requirements and then summarizes the results of
previously published intervention trials in which add-
itional protein or selected amino acids were provided to
young children at risk of stunting.
ESTIMATED PROTEIN REQUIREMENTS OF
YOUNG CHILDREN
The protein requirements of infants and children are
defined as the minimum intake that will allow nitrogen
equilibrium during energy balance (for maintenance)
plus the amount needed for deposition of new tissues
(for growth).7 Protein requirements are expressed per
kilogram body weight (BW). The World Health
Organization (WHO), FAO, and the United Nations
University (UNU)7 estimated daily protein require-
ments of infants and children at 0.66 grams per kilo-
gram BW for maintenance, plus age-related
requirements for growth, which decrease progressively
as growth velocity slows in older children (Table 17–9).
The US Institute of Medicine published similar esti-
mates to those issued by WHO/FAO/UNU,9 with the
amino-acid requirements of children expressed per
kilogram BW and decreasing with age (Table 26,7).
Dietary protein available to the body and utilizable
for protein metabolism depends on the digestibility of
the protein and its amino-acid composition. The pro-
teins in breast milk and animal-source foods are consid-
ered to be of “good quality” because they are highly
digestible and comprised of more than adequate
amounts of all of the essential amino acids. Plant-based
foods tend to have poorer quality protein because their
proteins are less digestible and contain lower amounts
of some essential amino acids, particularly lysine and
sometimes tryptophan (in cereals) and sulfur-
containing amino acids (in legumes). The quality of
dietary protein intake can be assessed by calculating a
protein digestibility-corrected amino acid score
(PDCAAS), which is the product of the digestibility
(proportion of protein digested and absorbed) and the
lowest ratio of each amino acid in the diet (or food) to
the amino-acid composition of a reference protein.6
The reference scoring pattern of amino acids used in
calculating the PDCAAS is presented in Table 2, and
sample calculations of the PDCAAS for single foods are
Table 1 Estimates of protein requirements of infants and children from the World Health Organization/Food and
Agriculture Organization of the United Nations/United Nations University and Institute of Medicine
Age Maintenance,
g/kg body weight
per day
Growth,
g/kg body
weight
per day
Average total
requirement, g/kg
body weight
per day
Recommended
intake (average
requirement
þ2 SD), g/kg body
weight per day
Median
body
weight, kg
Recommended
intake (average
requirement
þ2 SD), g/d
World Health Organization/Food and Agriculture Organization of the United Nations/United Nations Universitya
0.5 y 0.66 0.46 1.12 1.31 7.6 10.0
1 y 0.66 0.29 0.95 1.14 9.3 10.5
1.5 y 0.66 0.19 0.85 1.03 10.6 10.9
2 y 0.66 0.13 0.79 0.97 11.9 11.5
3 y 0.66 0.07 0.73 0.90 14.1 12.7
4 y 0.66 0.03 0.69 0.86 16.2 13.9
5 y 0.66 0.03 0.69 0.85 18.3 15.5
Institute of Medicineb
7–12 mo 0.69 0.31 1.00 1.20 9 11
1–3 y 0.69 0.18 0.87 1.05 12 13
4–8 y 0.69 0.07 0.76 0.95 20 19
aData from Table 33a in World Health Organization/Food and Agriculture Organization of the United Nations/United Nations University
(2007).7 The protein requirement for growth for 5 years was modified due to a presumed error (0.06 g/kg) in the report. Values were
only provided on a gram per kilogram body weight basis. The recommended intake level of protein per day was calculated using me-
dian body weights from World Health Organization child growth standards for specified age.8
bData from Institute of Medicine (2002).9
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depicted in Supplementary Table S1 (see Table S1 in the
Supporting Information online). The PDCAAS can also
be used to characterize whole diets by calculating the
sum of digested amino acids from all foods and com-
paring it with the scoring pattern, as illustrated by the
example in Supplementary Table S2 (see Table S2 in the
Supporting Information online). The PDCAAS can be
used to adjust the total dietary protein intake to esti-
mate the amount of protein in the diet that is available
to the body—that is, “available” protein¼ total protein
intake PDCAAS.7 The amount of PDCAAS-adjusted
(or available) protein provided by a food or a mixed
diet is not usually described in publications of interven-
tion trials, so in cases where the available protein
intakes could be calculated from the studies reviewed
here, that information has been provided using the
methods presented in Supplementary Tables S1 and S2
(see Tables S1 and S2 in the Supporting Information
online).
REVIEWS OF INTERVENTION TRIALS
The results of intervention studies that provided supple-
mentary protein or amino acids to children aged 6–35
months and reported growth outcomes are reviewed
below. Growth outcomes may include changes in
weight or length in absolute terms or in relation to
established growth indices, such as Z scores, with re-
spect to reference values. To address the question of
whether inadequate protein intake is a cause of growth
restriction in children, the most useful studies are ones
that provided supplemental protein to randomly
selected groups of children and compared their growth
with the growth of children who did not receive supple-
mental protein. Ideally, such randomized intervention
trials should be conducted in populations with a high
risk of stunted growth and among children within the
age range in which stunting occurs. The usual baseline
protein intakes in the study populations should be
suspected to be inadequate or marginally adequate in
relation to estimated requirements, and information on
total protein intake should be collected during the study
period to monitor adherence to the intervention and
potential displacement of the usual diet. The interven-
tion groups should differ only in relation to their pro-
tein or amino-acid intakes, and energy and other
nutrients required for growth should be provided in ad-
equate amounts. The duration of the intervention
should be sufficient to assess linear growth. Finally, the
sample size should be adequate to examine potential
modifying factors, such as initial anthropometric status,
diet, and morbidity. These considerations were taken
into account when examining the studies reviewed in
this article, although few of the available studies success-
fully addressed even a subset of these issues.
METHODS
A PubMed search was conducted in February 2015
using the following search terms: [(children or infants)
AND (protein or amino acids) AND (supplementation
or intervention) AND growth]. Additional searches
were conducted for each essential amino acid using the
following search terms (example for lysine): [(lysine)
AND (children or infants) AND growth AND (supple-
mentation or intervention or fortification or fortified)].
The titles and abstracts of all articles were reviewed
for appropriateness. Additional references were identi-
fied from articles found during the search. Studies with
children aged 6–35 months were included. The majority
of studies identified were excluded due to1 of the fol-
lowing reasons: (1) study not an intervention trial, (2)
age of children outside of target age range, (3) children
had clinical conditions other than recovery from mal-
nutrition that could affect their growth, and (4) inter-
ventions differed by other nutrients in addition to
protein.
Table 2 Amino-acid requirements of children and scoring patterns for protein quality assessment
Age, y Amino acid
Histidine Isoleucine Leucine Lysine Sulfur-amino acids Aromatic-amino acids Threonine Tryptophan Valine
Requirement (mg/kg body weight)a
0.5 22 36 73 64 31 59 34 9.5 49
1–2 15 27 54 45 22 40 23 6.4 36
3–10 12 23 44 35 17 30 18 4.8 29
Scoring pattern (mg/g protein requirement)b
0.5 b 20 32 66 57 27 52 31 8.5 43
1–2 18 31 63 52 25 46 27 7.4 42
3–10 16 31 61 48 23 41 25 6.6 40
aAmino acid requirement data are from Table 36 in World Health Organization/Food and Agriculture Organization of the United
Nations/United Nations University (2007).7 The requirements for the sulfur amino acids were modified due to calculation errors identi-
fied and reported in Table 3 in Food and Agriculture Organization of the United Nations (2013).6
bThe 2013 Food and Agriculture Organization of the United Nations report6 recommends the scoring pattern for infants aged 0.5 years
be used for young children (6 months to 3 years).
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Eighteen studies were identified for inclusion in
this review. Information on the studies was extracted by
1 author (J.E.A.) into an Excel spreadsheet with the fol-
lowing information, if available: author, year, research
site, type of protein or amino acid, study participants,
study design, intervention description, baseline anthro-
pometry, growth outcomes, other outcomes, statistical
analysis method, diet information, and study limita-
tions. Eight of the studies were conducted in hospital-
ized children recovering from acute malnutrition, and
the following interventions were used: lysine-
supplemented cereals (n ¼ 4), quality protein maize
(QPM) (n ¼ 1), potato as the protein source (n ¼ 1),
and varied levels of energy from cow’s milk protein
(n ¼ 2). Ten studies were community-based trials that
examined the following types of intervention: QPM
(n ¼ 7), glutamine (n ¼ 1), and lipid-based supple-
ments that varied protein source or amount (n ¼ 2).
Results of this review are presented according to the 2
categories of inpatient and community-based trials.
RESULTS AND DISCUSSION OF PROTEIN
SUPPLEMENTATION TRIALS
Inpatient studies conducted in children recovering
from acute malnutrition
The 8 studies in this category were all conducted in
Peru by the same set of investigators working with
children who had been hospitalized previously for treat-
ment of severe, acute malnutrition. Four small, short-
term studies were designed to determine whether
supplemental lysine added to cereal-based diets would
increase weight gain and linear growth.10–13 Among the
remaining studies, 1 tested QPM14 and 1 tested potato15
as a protein source, and 2 evaluated the adequacy of dif-
ferent levels of protein intake for children recovering
from malnutrition.16,17 Details of the studies are sum-
marized in Table 310–17 Additional details on the dietary
intakes and estimated PDCAAS of the diets are pro-
vided in Table 410–14 for studies that provided sufficient
information.
The 4 lysine studies conducted in Peru each used a
similar crossover design with 6–13 children in each
group. In general, the children were enrolled after a
steady state of weight gain was achieved, and the energy
level of diets was set to maintain a specified rate of
weight gain, with 6.4%–8.0% of energy from protein.
Three of the 4 studies examined the effects of feeding
the children wheat-based diets and additional lysine,
which is the most limiting amino acid in wheat. If wheat
is the sole source of protein, the PDCAAS-adjusted pro-
tein is approximately 45% of the crude protein; this is
due primarily to the low amount of lysine in wheat (see
Supplementary Table S1 in the Supporting Information
online). In the fourth trial, sorghum was the sole source
of protein, with a PDCAAS of 27%.
Two studies with almost identical design were con-
ducted to determine the amount of lysine that should
be added to wheat flour for maximal improvement in
biological value, measured as nitrogen retention, and
rates of weight gain, while isocaloric and isonitrogenous
diets were consumed for 15–36 days in the first study10
or 3–6 months in the second one.11 Six children were
enrolled in each study after they had achieved a steady
rate of weight gain. The children were fed a diet with
casein as the unique protein source before and after
randomly sequenced diets in which wheat was the only
protein source, with or without 1 of 3 levels of add-
itional lysine (see Tables 3 and 4). The wheat flour used
in the diets was higher in protein content (21 g protein/
100 g of flour) than ordinary wheat flour (approxi-
mately 10 g protein/100 g) and the lysine content of the
flour was 26.7mg/g of protein. Total protein intakes
were designed to provide 2 g/kg BW. The authors noted
that all of the diets provided less lysine than the esti-
mated requirement of 90 mg/kg BW, but the more re-
cently updated FAO estimate of lysine requirement is
much lower, ie, 44mg/kg BW for a child aged 1–2
years.7
The children’s weight gains during the 4 diet phases
were expressed as a percentage of the rate achieved dur-
ing the preceding and following casein periods, which
was a mean of 3.8 g/kg BW/d. The mean expected rate
of weight gain for children of the same chronological
age is about 0.7 g/kg BW/d, and the mean expected rate
of weight gain for children with the same mean weight
of 7 kg (which corresponds to a chronological age of 4–
6mo) is 2–3 g/kg BW/d (based on the 2006 WHO
growth standards8). Thus, these children were gaining
weight more rapidly than expected for age or BW dur-
ing all of the dietary periods and had greater protein
requirements than normal-weight children.
In the first study, the mean rates of weight gain
were not different for children receiving the wheat-only
diet versus the wheat with 0.12% lysine enrichment
diet; the former group achieved 67% of the rates of
weight gain recorded during the 2 casein periods, and
the latter group achieved 83% of the rate recorded dur-
ing the casein periods. By contrast, rates of weight gain
differed significantly (P< 0.05) between the wheat-only
diet (67% of the rate achieved with casein) and the
wheat with 0.2% lysine enrichment diet (97% of the rate
achieved with casein) and the wheat with 0.4% lysine
enrichment diet (91% of the rate achieved with casein).
Nitrogen retention also increased during each of the 3
periods with added lysine and was similar among the 2
highest lysine-enriched wheat diets and the casein diets,
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which led the authors to conclude that gains in protein
value were evident with the 0.12% level of lysine enrich-
ment, further gains occurred with enrichment at the
0.2% level, and no further gain was seen at the 0.4%
level.
In the second study, 2 children each received
lysine-enriched wheat flour at 1 of 3 enrichment levels
as their only source of dietary protein for 3–6 months.11
The children’s energy intakes were in the range of 100–
150 kcal/kg and actual protein intakes before correcting
for the PDCAAS were in the range of 1.65–2.5 g/kg BW.
The authors described each child’s growth in terms of
height-age or weight-age (referring to the age at which
the child’s height or weight is in the 50th percentile of
the US growth reference) and height or weight quotient
(100 height- or weight-age/chronological age). Most
of the children had height and weight ages far below
their chronological age. One of the 2 children receiving
wheat enriched with 0.12% lysine achieved height and
weight gains exceeding gains in chronological age while
receiving 8% of energy as protein (approximately 1.26 g
of available protein per kg BW), indicating catch-up
growth; specifically, over 4.5 months, this child pro-
gressed in height-age by 5.5 months and in weight-age
by 11.5 months. The other child receiving wheat
enriched with 0.12% lysine and only 6.6% of energy as
protein (approximately 1.0 g of available protein/kg
BW) had lower increases in height- and weight-age
(2mo) than chronological age (3mo). Among the 2
children who received wheat enriched with 0.2% lysine,
1 child who received 8% of energy as protein (approxi-
mately 1.48 g of available protein/kg BW) had gains in
height and weight age that matched the increase in
chronological age (4.5mo). The second child who
received wheat enriched with 0.2% lysine, initially at
6.7% protein energy (1.85 g of available protein/kg BW)
and later at 8% protein energy, had a gain in weight-age
(12.5mo) that exceeded the gain in chronological age
(4.5mo), but a gain in height-age (3.5mo) that was
slightly below the gain in chronological age (4.5mo).
The 2 children who received wheat enriched with 0.4%
lysine (predominately at 8% of protein energy and 1.7–
2.2 g available protein/kg BW) had growth rates that
exceeded those for chronological age. The authors con-
cluded that wheat flour enriched with 0.1%–0.4% lysine
can serve as the only source of protein in the diet for
several months when the diet provides at least 8% of en-
ergy as protein; however, if the diet provides 6.4%–8%
of energy from protein, 0.2%–0.4% lysine enrichment
would be needed.
A third study was conducted in 13 Peruvian chil-
dren recovering from malnutrition to determine
whether a diet providing 75% of energy and 100% of
protein as wheat could support satisfactory growth.12
The diets provided 100–160 kcal/kg BW/d, based on
levels previously shown to maintain weight gain within
an acceptable range of 3–7 g/kg BW/d for recovering
malnourished children. When wheat was provided as
50% of energy and 77%–80% of protein, weight and
height gains exceeded the expected gains for age; the
average weight gain was 546% of the median amount
expected for age, and height gain was 195% of expected.
When wheat was provided as 75% of energy and 100%
of protein, weight gain was greater than expected for
age (252%), but linear growth was less than expected for
age (86%). Finally, when wheat was provided as 75% of
energy in periods with or without supplemental lysine
at 0.2% enrichment, the lysine supplementation pro-
duced increases in weight gain (mean 567% of gain
expected for age) that exceeded those in the nonlysine
periods (mean 331% of gain expected for age). The
period of lysine supplementation in this study was too
short to assess gains in body length, but overall, during
the entire period of the third diet (most of which did
not include lysine supplementation), linear growth was
inadequate. The authors concluded that supplemental
protein or lysine is needed for infants consuming diets
in which wheat provides 75% of energy.
The fourth study reviewed examined the impact of
feeding a sorghum-based diet with and without lysine
to infants recovering from acute malnutrition.13 Ten
children were each fed 4 diets over 9-day periods; the
diets included a casein control diet during the first and
last periods and diets of fermented sorghum flour (1
with lysine and 1 without lysine) as the source of pro-
tein during the middle 2 periods. Weight gains were
significantly higher with the casein diet compared with
the sorghum diets but they did not differ between the
sorghum diets with and without lysine. Apparent nitro-
gen retention was significantly lower during the sor-
ghum without lysine dietary period (26%) than during
the sorghum with lysine dietary period (34%) or the ca-
sein periods (35% and 49%, for periods 1 and 4, respect-
ively), suggesting that the higher weight gains during
the casein periods were reflective of the increased nitro-
gen retention due to higher protein quality. The higher
nitrogen retention in the second casein period com-
pared with the first indicates compensation for inad-
equate retention during the sorghum periods. The
mean intake of PDCAAS-adjusted protein was above
the protein requirements for children of this age range
(0.73–1.12 g protein/kg BW, depending on age) when
children consumed the sorghum flour with lysine
(0.92 g/kg BW) but not the sorghum flour without ly-
sine (0.63 g/kg/BW) (Table 4).
A fifth study compared the growth rates of 20 chil-
dren who were fed either QPM or cow’s milk formula
for 90 days.14 The QPM had a lysine content of 40mg/g
706 Nutrition ReviewsVR Vol. 75(9):699–717
protein and 9.2mg tryptophan/g protein and an esti-
mated PDCAAS of 60% based on the lysine require-
ment pattern of 57 mg/g protein. The mean intake of
the children receiving QPM was 110 kcal/kg BW and
2.63 g of protein (or 1.6 g of available protein)/kg BW.
The mean rate of growth was 2.63 g/kg BW/d, which
was comparable to the rate achieved by children con-
suming cow’s milk formula (2.6 g/kg BW/d), who were
consuming an estimated 2.01 g available protein/kg
BW. Although the estimates of available protein from
the QPM used in the study are not certain, the estimates
were well above the recommended intake level for chil-
dren in this age range (1.0–1.1 g/kg BW), and this study
suggests that the QPM adequately supported the child-
ren’s growth.
A sixth study, which involved 10 children recover-
ing from malnutrition in Peru included 3 isonitroge-
nous, isocaloric diets with varying proportions of
energy and protein from potato.15 The initial energy in-
take was estimated based on the amount required dur-
ing the 2 weeks preceding the start of the study to
promote a weight gain of 2–4 g/kg BW/d while consum-
ing a cow’s milk formula with presumably adequate
protein content. Each of the study diets contained 2 g
protein/100 kcal (8% of energy from protein) but the
amounts of potato and casein as the protein sources
varied (Table 3). The third diet, which contained 84%
of energy and 100% of protein from potato, was subse-
quently dropped because the first 2 infants who
received it were not able to consume it in sufficient
quantities. In the 2 remaining diets, the children’s mean
daily energy and protein intakes were 124 kcal/kg BW
and 2.5 g/kg BW (2.15 g available protein/kg BW) for
the diet with 50% energy and 60% of protein from po-
tato, and 129 kcal/kg BW and 2.58 g/kg BW (2.11 g
available protein/kg BW) for the diet with 75% of en-
ergy and 89% of protein from potato. All of the children
in these 2 groups gained weight at a rate equal to or
greater than expected for their age. The small number
of children (and the small differences in available pro-
tein intakes) precluded the detection of any differences
between the 2 diets, but the authors concluded that
both diets allowed for adequate growth.
A Peruvian study of 6 infants recovering from mal-
nutrition evaluated an isoenergetic diet with varying
levels of protein from cow’s milk formula.16 The chil-
dren received 4 different levels of protein: (1) 4% of en-
ergy, (2) 5.3% of energy, (3) 6.4%–6.7% of energy, and
(4) 8% of energy. The order of administration of the
diets was randomized and each diet was provided for 14
days. The rates of weight gain were significantly lower
during the 4% energy diet period (2.8 g/kg/d) than dur-
ing the periods of 5.3% energy (5.2 g/kg/d; P< 0.05)
and 6.4%–6.7% energy (6.7 g/kg/d; P< 0.01). The mean
weight gain during the 8% energy period was 6.6 g/kg/d,
which is similar to that of the 6.4%–6.7% diet; how-
ever, it was not compared statistically with the 4% diet
because 2 of the children did not receive the 8% energy
diet. This small study suggests that weight gain was
greater with diets providing 5.3% or 6.4%–6.7% energy
from cow’s milk protein compared with 4%, but there
was no further increase with diets providing 8% of en-
ergy as protein.
A study of 81 children recovering from malnutri-
tion in Peru evaluated the adequacy of recommended
protein intakes for young children.17 Children were div-
ided into 2 length-age strata and were randomly
assigned to receive 1 of 3 isocaloric diets consisting of
cow’s milk formula with varying levels of protein con-
tent for 3 months. Forty-four younger children aged
5–18 months who had an initial length age of 2.5–6.4
months received 5.5%, 6.7%, or 8% of energy from pro-
tein. Thirty-seven older children aged 11–32 months
with a length-age of 6.1–17.9 months received 4.7%,
6.4%, or 8% of energy from protein. The lowest protein
diets were designed to meet the 1985 FAO/WHO/UNU
recommended safe level of protein intake of 1.47 g/kg
BW/d for children aged 3–4 months and 1.15 g/kg
BW/d for children aged 9–12 months18. Energy content
of the diets was estimated to be sufficient to support an
increase in length-age of 3 months and an increase in
weight to the median length-age over the course of the
study. The actual mean intakes of protein per kilogram
BW for the younger children were 1.7, 1.9, and 2.5 g/kg
BW for the 5.5%, 6.7%, and 8% protein diets, respect-
ively. Older children consumed 1.3, 1.6, and 2.1 g pro-
tein/kg BW for the 4.7%, 6.4%, and 8% protein diets,
respectively. There were no differences between groups
in weight gain or linear growth. The authors noted that
the lowest protein diet in the younger age stratum may
have been marginally limiting linear growth, but the
small numbers of younger children in the 3 dietary
groups (n¼ 14–15) may have prevented their ability to
detect a small statistical difference from the other diets.
Based on current 2007 WHO/FAO/UNU protein rec-
ommendations,7 which are slightly higher than the 1985
guidelines, the lowest protein energy diet for the young-
est children met the recommended intake level of
1.31 g/kg BW/d. For the older children in the lowest
protein cell, a protein intake of 1.1 g/d (2 SD below the
mean of 1.3 g) was sufficient for adequate growth. This
study demonstrates that additional protein intake above
the WHO/FAO/UNU estimated requirement did not
appear to provide any additional benefit for growth
during recovery from malnutrition.
The studies reviewed in this section are mostly lim-
ited by their small numbers of children and the short
durations of supplementation in which to assess growth,
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particularly linear growth. Moreover, the children were
all recovering from acute malnutrition that had been
serious enough to require hospitalization. Although the
children were enrolled after their weight gain and other
indicators of protein status were improved, it is unclear
how generalizable the findings are to the growth re-
sponse of more mildly undernourished or otherwise ad-
equately nourished children with lower expected
growth rates. The last study described was especially in-
formative in that it was designed to determine the ad-
equacy of a then newly recommended (FAO/WHO/
UNU 1985)18 intake level of protein (4.7%–5.5% of en-
ergy, depending on age) compared with 2 higher levels
for growth of children recovering from malnutrition,
and all diets were isocaloric, only differing in the
amount of protein from cow’s milk. Providing add-
itional protein above the estimated requirement did not
convey any additional benefit for the growth of these
children. In these studies, the children experienced
varying rates of “catch-up growth,” as evidenced by
higher rates of weight gain than expected for their age
or body size, even within recommended protein intake
ranges; this suggests that recommended protein levels
should support adequate growth in generally healthy
children. These studies are also informative for examin-
ing the relationship between estimated available protein
intakes and rates of weight gain among children recov-
ering from malnutrition, which is discussed further
below.
Community-based trials with food-based protein or
amino-acid supplementation
Ten community-based trails were examined in this re-
view: 7 with QPM,19–22 1 with glutamine,23 and 2 with
lipid-based nutrient supplements.24,25 The latter 2 stud-
ies tested the difference between soy and milk protein.
These studies are summarized in Table 5.19–25
Opaque-2 varieties of maize bred for improved pro-
tein quality, specifically higher concentrations of lysine
and tryptophan, were developed in the 1960s. Earlier
varieties had problems with lower yields and suscepti-
bility to pests that precluded their adoption, but
improved varieties with better agronomic properties,
referred to as QPM, are now available more widely, par-
ticularly in sub-Saharan Africa. The lysine and trypto-
phan concentrations of QPM are approximately double
the concentrations in conventional maize (CM)
varieties.
Seven studies that compared the growth of children
consuming QPM with that of children consuming ei-
ther cow’s milk formula or CM were identified. Six of
these 7 studies were included in a previously published
meta-analysis by Gunaratna et al.,19 which examined
the impact of QPM versus CM on child growth. The
meta-analysis included results from 7 studies conducted
in Ethiopia, India, and Ghana. Children were aged<5
years, although most were<24 months of age at base-
line. Quality protein maize was associated with a 12%
(95% confidence interval [CI], 7%–18%) greater rate of
weight gain (P¼ 0.0002) and a 9% (95%CI, 6%–15%)
greater rate of height gain (P< 0.0001), although meth-
odological limitations of the individual studies preclude
definitive conclusions. Six of the 7 individual studies
included children aged<36 months and are described
in the following paragraphs.
A cluster-randomized study conducted in Ethiopia
provided either QPM or CM seeds to households in suf-
ficient quantity to meet the household’s maize needs for
1 year.20 The study assessed the growth of 151 children
aged 5–29 months over a 13-month period. Initially,
30% of children were stunted. Over the 13 months,
changes in length-for-age and weight-for-age Z scores
did not differ between groups, although there was a
marginal difference in the change in weight-for-length
Z score (P¼ 0.048). In particular, children in the QPM
group reportedly gained significantly more weight
(167 g/mo) than the children in the CM group (146 g/
mo), but the statistical significance of the results was
not reported. Both groups of children grew an average
of 0.77 cm/month. Dietary information revealed that
95% of the children were still breastfeeding at baseline
and that complementary feeding consisted primarily of
maize; at baseline, only 31% of the children received
foods other than maize, and this was usually teff, an-
other grain that is also limited in lysine but higher in
protein (13% of energy) than maize (9% of energy).
Throughout the study, even fewer of the children
received other foods, particularly during the preharvest
season when only 10% of children received foods other
than maize. Lack of quantitative dietary information on
consumption of maize, total energy, and protein intakes
makes it difficult to interpret the lack of overall impact
on weight-for-age or length-for-age Z scores.
A study in India assessed the impact of providing
QPM in comparison with CM or milk on the growth of
children.21 One hundred thirty-two children aged 18–
30 months who were at least 60% of the median weight-
for-age were assigned to 1 of 3 experimental groups
(QPM, CM, or skim milk powder) or a control group.
Children in the experimental groups received a midday
meal that was designed to provide an average of
405 kcal and 10 g protein/d for 6 months. The mean
weight gains over the 6 months were 1.3 kg for the
QPM group, 1.2 kg for the milk group, 1.04 kg for the
CM group, and 0.72 kg for the control group; and mean
height gains were 4.22 cm for the milk group, 3.87 cm
for the QPM group, 2.99 cm for the CM group, and
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2.86 cm for the control group. The authors concluded
that QPM was superior to CM and similar to skim milk
for supplementary feeding of young children, but no
statistical analyses were reported, so this conclusion is
uncertain. Moreover, studies of the children’s total diet-
ary intakes suggested that all were receiving 2–3-fold
higher amounts of protein than their theoretical
requirements, so it is difficult to understand why they
would have responded to increased protein intake if the
dietary data were, indeed, accurate.
A series of 4 studies conducted in Ghana were
included in the meta-analysis by Gunaratna et al.19 and
are described in a report by the Ghana Health Service.22
The first 2 trials were pilot or exploratory, the third trial
was the main study testing the efficacy of QPM versus
CM, and the fourth trial included an energy supplement
in addition to the maize. The report stated that the
QPM contained 70% higher amounts of lysine and tryp-
tophan than CM.
In the first study, seed was provided to 140 house-
holds with random allocation of QPM and CM. The
children were aged 4–23 months, and anthropometric
measurements were taken over 12 months. Data were
only available for 83 children throughout the study due
to attrition. There were no differences in weight or
height gains between the QPM and CM groups. The se-
cond study provided QPM and CM in the form of
dough to 120 households with children aged 4–15
months for 12 months. Data were available for 78 chil-
dren at the end of the study. Children receiving QPM
had a mean gain in height that was 2.4 cm greater than
children receiving CM (P¼ 0.03). The high attrition
rate and the failure to assess the characteristics of chil-
dren who did and did not complete the study under-
mine the usefulness of these results.
The third trial was designed to provide maize
dough to 321 children aged 4–9 months for 12 months.
Eighteen percent to 20% of the children were stunted at
baseline. Children receiving QPM had a 1-cm greater
increase in height than the children receiving CM
(P¼ 0.0001). At the end of 12 months, 24% of children
who received QPM were stunted compared with 43% of
children who received CM (P< 0.05). In addition, the
children who received QPM had fewer days ill from the
third month of the study onward than children who
received CM, although it was unclear how an illness day
was defined.
Based on poor weight gains in the third trial, which
was attributed to the high water content of the maize
porridge, a fourth trial was designed to provide add-
itional energy without excess bulk by adding barley
malt to maize dough. Maize dough (QPM or CM) with
and without barley malt was provided to 600 children
aged 4–6 months for 7 months. Four hundred
eighty-six children remained at the end of the study and
were included in the analysis. The dough with barley
malt provided approximately 3 times the energy as the
dough without malt. Children receiving QPM with bar-
ley malt gained 0.5 kg more than the children receiving
CM with barley malt (P< 0.01). There were no significant
differences in length gain in children who received QPM
with barley malt versus those who received CM with bar-
ley malt, nor in either weight or length gains in children
who received QPM or CM without barley malt.
Some information on energy and protein intakes of
the children was reported for the third and fourth trials,
although not very clearly. For trial 4, only the average
intakes of the mpampa (maize porridge with barley
malt) and koko (maize porridge without barley malt)
were presented, which provided an average of approxi-
mately 350 kcal/d and 100 kcal/d, respectively. Total
protein intakes could not be estimated from the infor-
mation provided. It is unclear why in the fourth trial
there was no difference in growth measures between
the QPM and CM without barley groups when in the
third trial there was a difference. It appeared there was
lower consumption of koko in the fourth trial (100 kcal/
d vs 150 kcal/d in trial 3), which may have been due to a
slightly younger age range and the duration of study in
trial 4.
The QPM studies reviewed here were all conducted
in areas with a high risk of stunting. Although the
meta-analysis reported a positive impact of QPM on
weight gain and linear growth, most of the studies can-
not be considered to be of adequate quality to draw
conclusions. Of the 6 studies, only 1 conducted a longi-
tudinal analysis of growth controlling for baseline sta-
tus, and that study did not find an impact on changes in
length-for-age Z score or weight-for-age Z score after
1 year.20 Only 2 of the studies were published in peer-
reviewed journals,20,21 and 1 did not report any statis-
tical analyses and did not specify the method of alloca-
tion to treatment groups.21 The 4 studies conducted in
Ghana were not peer-reviewed and had high loss to
follow-up due to movement from the study area.22 Two
of the 4 studies were small preliminary studies. As pre-
viously mentioned, the dietary protein intakes of the
children were not well documented, which makes it dif-
ficult to assess the protein adequacy of the baseline diet
in the studies that reported no impact of QPM.
Therefore, the efficacy of QPM for child growth based
on these studies remains uncertain.
A community-based trial conducted in Gambia,
where disease and growth faltering are common among
children, was conducted to determine if glutamine
would have an impact on intestinal mucosal damage
and growth of infants (Table 5).23 Glutamine is a nones-
sential amino acid, although it is thought to be
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“conditionally essential” during illness or injury. The
double-blind, placebo-controlled, randomized trial was
conducted during 5 months of the rainy season.
Ninety-three infants aged 4–10 months were random-
ized into 1 of 4 groups: 2 of the groups received glutam-
ine (0.5 g/kg BW daily), and 2 of the groups received an
isonitrogenous, isoenergetic mix of nonessential amino
acids and fructose. No differences in growth were found
between the 2 groups at the end of the study. Mean
weight gains were 60 g/mo and 69 g/mo, and height
gains were 1.01 cm/mo and 0.95 cm/mo in the glutam-
ine and placebo groups, respectively. Weight-for-age Z
scores decreased during the study from an initial mean
of1.70 and1.69 to a final mean of2.69 and2.58
in glutamine and placebo groups, respectively. Height-
for-age Z score decreased during the study from an ini-
tial mean of1.23 and1.33 to a final mean of1.73
and1.76 in glutamine and placebo groups, respect-
ively. No differences between groups were detected for
intestinal permeability measures.
This trial was conducted in a population at risk of
stunting. The daily provision of glutamine was nearly
half of their protein requirement of 1.12 g/kg BW and
the only difference in the treatment groups was the pro-
vision of glutamine versus other nonessential amino
acids. There was no information provided on dietary
intakes to permit assessment of the protein adequacy of
the baseline diet. Nevertheless, there was no evidence of
any growth impact of this particular amino acid.
Two community-based studies with a lipid-based
micronutrient-fortified spread allow for the comparison
of different sources of protein (milk or soy) that were
added to the spread, which was otherwise equal in en-
ergy and micronutrient contents.24,25 The first was a
preliminary study conducted in Malawi that provided
the respective products to children for 12 weeks.24 A
total of 128 children aged 6–17 months who were
underweight (weight-for-age Z score less than2) were
randomized to 1 of 8 treatment groups. Six groups
received a spread that was either milk based (dried
skimmed milk) or soy based (defatted soy flour) and
provided in 3 different doses (25, 50, and 75 g/d), 1
group received 5 g/d of a milk-based spread, and 1
group did not receive any supplement. Pertinent to this
review are the comparison groups receiving the same
amounts of either milk or soy-based spread, as they pro-
vided similar amounts of energy and protein but differ-
ent types of protein varying in quality (although the
PDCAAS could not be calculated from the information
presented in the published report). The amounts of pro-
tein provided by the 25 g/d, 50 g/d, and 75 g/d supple-
ments were 3–4 g, 7–8 g, and 10–11 g, respectively. No
significant differences in growth were detected among
comparable groups of children receiving the same doses
of milk- or soy-based spreads. The study was consid-
ered preliminary, and its short duration and small num-
bers of children per group may have limited the ability
to detect impacts on growth. At a mean initial weight of
7.5 kg, the estimated average protein requirement of the
children was approximately 7–8 g/d. No baseline dietary
information was reported to assess whether the child-
ren’s diets were limited in protein. It appears that the
children did not benefit from the higher quality protein
in the milk-based supplement or the higher amounts of
protein over this short period of time.
The second study conducted in Malawi by the
same researchers provided fortified spreads or corn-
flour blend supplements to children for a longer dur-
ation.25 Eight hundred forty children aged 6 months
were randomized to 1 of 4 groups: a group that received
a lipid-based nutrient supplement (LNS) with dried
milk (milk-LNS), a group that received LNS with soy
flour (soy-LNS), a group that received a corn-soy flour
blend (CSB), or a control group that received no sup-
plement for 12 months. The comparable groups of
interest here are the children who received milk-LNS or
soy-LNS because they had similar nutrient contents and
the supplements contained 8.2 g and 7.5 g of protein, re-
spectively. There were no significant differences in
weight gain or linear growth between children who
received the milk-LNS and children who received the
soy-LNS. The mean length-for-age Z scores were
approximately1.6 to1.7 initially and decreased in all
groups. During the 9–12-month age period, the milk-
LNS group did have a significantly smaller decrease in
length-for-age Z score (0.23) than the control group
(0.31; P¼ 0.03) or the CSB group (0.38; P¼ 0.01),
but not the soy-LNS group (0.28; P¼ 0.08). At the be-
ginning of the study, the children’s average estimated
protein requirement was approximately 7.8 g/d (1.12 g/
kg BW), and at the end of the study their protein re-
quirement was approximately 8.2 g/d (0.86 g/kg BW).
Therefore, the supplement alone should have met their
average protein requirements, assuming all of it was
consumed. No information on the children’s diets was
provided, except that almost all children were receiving
breast milk throughout the entire study. Although it
might be possible that, if the children were consuming
an amount of protein close to their requirement, they
could have had some slight benefit to the higher protein
quality in the milk-LNS, this seems unlikely as the ac-
tual difference in estimated available protein from the
milk-LNS (95% of 8.2 g) and soy-LNS (86% of 7.5 g) is
only approximately 1.3 g.
The longer study in Malawi had a suitable design,
but the study population was already moderately
stunted at 6 months of age, which indicates that other
factors, such as prenatal influences, inadequate early
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diet, and morbidity, were affecting growth, and the
amount and quality of the protein in the children’s
diets, other than that provided by the supplement, were
unknown. Despite these limitations, there is no evi-
dence from this study to suggest that increasing the
children’s protein intake above baseline levels affected
their growth.
DISCUSSION
This review identified a remarkably small number of
intervention studies that specifically examined the inde-
pendent impact of protein or amino-acid supplementa-
tion on child growth. Many of the studies were
conducted several decades ago at small inpatient facili-
ties among children recovering from acute malnutri-
tion. Nevertheless, these studies offer insights into the
protein needs of children experiencing accelerated
growth in compensation for prior growth restriction.
Their findings suggest that the presently recommended
protein intake levels are sufficient to support acceler-
ated growth and, therefore, should also support children
with less severe malnutrition. The community-based
studies that provided supplementary protein or amino
acids did not demonstrate any consistent benefit of sup-
plemental protein for enhancing children’s growth. A
number of other recent studies have assessed the impact
of food-based supplements that contained protein on
children’s growth, but these supplements contained
other nutrients in addition to protein, so were not suit-
able for assessing the independent effect of protein and
were, therefore, not included in this review.
Nevertheless, many of these food-based studies also
failed to show improved growth among children who
received supplements that included protein along with
other nutrients,
26–29
suggesting that protein was not a
unique factor limiting their growth.
There are several possible reasons for the lack of ef-
fect of additional protein on children’s growth in these
studies: (1) initial dietary protein intakes were adequate
to meet growth requirements; (2) the supplement dis-
placed usual food intake, causing little or no net in-
crease in protein intake; (3) energy intakes were
inadequate despite the provision of the supplement; (4)
protein requirements were greater than normal because
of the need for catch-up growth due to previous malnu-
trition or concurrent infections, and the amount of sup-
plemental protein was insufficient to meet this need; or
(5) underlying intestinal dysfunction, infections, or sys-
temic inflammation prevented a growth response to the
increased protein intake.
The community-based studies reviewed here had
little information on the baseline dietary protein or en-
ergy intakes of the children. Thus, it is not certain
whether the lack of response in those studies was be-
cause the children in the study populations already had
adequate protein intakes but energy intakes were inad-
equate or because the supplement simply displaced part
of the usual diet, resulting in no net increase in protein
intake.
The initial anthropometric or nutritional status of
the children in the studies may have influenced the
results. In the studies conducted in Peru, children were
recovering from acute malnutrition and experiencing
accelerated growth; they thus had greater protein needs
than nonmalnourished or mildly malnourished chil-
dren, possibly increasing the likelihood of detecting a
growth impact from provision of additional “available”
protein. Nevertheless, these studies found that the rec-
ommended protein intakes supported the expected
growth rates for children of similar age and body size,
suggesting that they also would be adequate for non-
malnourished children. In the Malawi studies, many of
the children were already stunted or moderately stunted
when enrolled at 6 months25 or 6–17 months22 of age,
which may indicate other contextual factors limiting the
children’s growth, such as an earlier nutritional insult
occurring during pregnancy or preconception, and it is
unclear how this may affect the ability of the infant to
grow normally or respond to nutritional interventions
during early childhood.2
To further examine relationships between protein
intake and growth, estimates of available energy and
protein intakes and rate of weight gain per kilogram
BW were compiled from the 6 studies by Graham et al.
in which the data were available or could be esti-
mated.10,13–17 These 6 studies provided information on
122 children, all of whom were recovering from acute
malnutrition and were gaining weight more rapidly
than expected for age. A total of 92 data points were
included in a graph (Figure 1), with 86 points represent-
ing individual children and 6 points representing group
means due to unavailable data on individual children.
In all cases, weight gains exceeded the average expected
rates for children aged 6–12 months (1.2 g/kg BW/d)
and 12–24 months (0.7 g/kg BW/d), according to the
WHO growth reference values, indicating that even
with the lowest levels of available protein the children
were able to achieve the expected rate of weight gain for
age. At the observed accelerated rates of weight gain,
available protein intake was positively associated with
weight gain. In a linear regression model, a 1 g increase
in available protein per kilogram BW was associated
with a 1.94 g/kg BW greater weight gain (P< 0.0001;
R2¼ 0.34). The association was only slightly attenuated
by including energy intake (per kilogram BW) in the
model; the b-coefficient for available protein was 1.30
(P< 0.0001; R2¼ 0.38). In most cases, the amount of
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available protein provided to the children exceeded the
recommended intake level (1.0–1.1 g/kg BW for a 1-
year-old). The highest rates of weight gain were
achieved with cow’s milk formula and with wheat-based
diets with at least 0.2% lysine enrichment, which
resulted in a similar rate of gain as when children were
fed casein. These diets provided at least 1.4 g of available
protein per kilogram BW. There is some uncertainty
about the protein needs for catch-up growth due to
wide variation in the rates and composition of weight
gain and uncertainties about the actual efficiency of
protein utilization.7 Nevertheless, improvements in the
protein quality of grains appear to support accelerated
growth if sufficient quantities of both protein and en-
ergy are provided.
Few of the community-based studies reviewed
reported morbidity information of the children. The
interactions between protein, infection, and growth can
be viewed in 2 ways: diarrhea or other infections could
negatively affect the utilization of protein and result in
reduced growth, or adequate protein intake could re-
duce morbidity or gut dysfunction and positively affect
growth. The glutamine study reported no effect of sup-
plementary glutamine on diarrhea prevalence or
growth.23 The third QPM trial in Ghana reported that
children who consumed QPM had significantly fewer
days with illness (although the type of illness was not
specified) and greater height gains than the children
who consumed CM.20 A lysine supplementation trial in
Ghana, which was not included in the review because of
the older age of the children (mean age, 8 years),
reported significantly lower rates of diarrhea with lysine
supplementation but nonsignificant improvements in
growth indices over the 16-week trial.28 The impact of
lysine and other amino acids on diarrhea in younger
children, who typically experience higher diarrhea
prevalence and gut dysfunction than school-age chil-
dren, should be studied further. Also, infections in-
crease nitrogen losses, and it is estimated that protein
requirements increase by as much as 20%–25% due to
infections31–33; however, data in young children
regarding the additional protein needs during infec-
tion, particularly with chronic or recurrent subclinical
infections commonly seen in low-income countries,
are lacking.
CONCLUSION
In summary, although the community-based studies
reviewed here did not consistently indicate that provid-
ing additional protein or higher quality protein
increased children’s growth, the available studies were
suboptimal with regard to critical design issues that are
necessary to determine whether dietary protein inad-
equacy is an important cause of growth restriction. The
community-based studies did not quantify total protein
intakes, including breast milk, or the quality of protein
in the diets prior to the intervention, nor did they assess
biomarkers of protein status. It was, therefore, unclear
whether protein intake or protein utilization was inad-
equate. Although the results of some of the QPM trials
suggested an increase in growth, the results were
Figure 1 Association between rate of weight gain and available protein intake in Peruvian children aged 6–32 months recovering
from acute malnutrition. Available protein refers to the total protein intake adjusted for the protein-digestibility amino acid score
(PDCAAS). The estimated average requirement (EAR) and recommended intake (RI) of protein (2 standard deviations above EAR) for a child
aged 1 year are depicted by vertical lines, and the expected rates of weight gain are depicted in horizontal lines. The figure includes 92 data
points, 86 representing individual children from 5 studies [Graham et al. (1969)10; Graham et al. (1990)14; Lopez de Roma~na et al. (1981)15;
MacLean et al. (1979)16; and Graham et al. (1996)17] and 6 representing group means [Graham et al. (1986)13] because data on individual chil-
dren were not available.
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inconsistent, and the poor quality of the studies
undermines their utility.
In order to examine whether additional protein
may improve growth in children at risk for growth fal-
tering, the following criteria are recommended for fu-
ture studies. Studies should target children who are in
the age range in which growth faltering typically starts
and when complementary foods are introduced (6–
12mo) and who reside in communities where the risk
of stunting during the first 2 years is high. Prior re-
search in the community should confirm that chil-
dren in the target age range have low or marginal
intakes of available protein in relation to current esti-
mated requirements or some other marker of low
protein status. The intervention should provide a suf-
ficient quantity of protein to bring total available pro-
tein intakes up to and above the estimated
requirements, considering the increased need for
protein during and after infections. The study should
also ensure that sufficient energy is provided so that
the supplementary protein can be utilized for growth
rather than potentially being diverted to meet main-
tenance energy needs. The intervention must be
delivered for an adequate duration to assess linear
growth. The sample size should also be large enough
to permit examination of potential effect modifiers,
such as diet, initial anthropometric status, and mor-
bidity, to identify the population subgroups most in
need of future intervention.
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